| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |
Cell Growth & Differentiation, Vol 9, Issue 2 131-138, Copyright © 1998 by American Association of Cancer Research
ARTICLES |
M Nacht and T Jacks
Howard Hughes Medical Institute, Center for Cancer Research, Massachusetts Institute of Technology, Cambridge 02139, USA.
The most common tumor in p53-deficient mice is thymic lymphoma, and p53 is known to be required for the induction of apoptosis in thymocytes following DNA damage. To examine whether the development of thymic lymphoma in p53-/- mice was dependent on the process of V(D)J recombination, we generated p53-/- mice that were also mutant for the Rag1 or Rag2 genes. Both Rag1-/-; p53-/- and Rag2-/-; p53-/- mice developed thymic lymphoma at high frequency, and the tumors arose with short latency. Interestingly, the thymic tumors were composed of CD4+CD8+ cells, although there was no evidence for normal V(D)J recombination. These data suggest that normal V(D)J recombination is not required for the development of thymic lymphoma in the context of a p53 germ-line mutation.
This article has been cited by other articles:
![]() |
M. Xu, Q. Yu, R. Subrahmanyam, M. J. Difilippantonio, T. Ried, and J. M. Sen {beta}-Catenin Expression Results in p53-Independent DNA Damage and Oncogene-Induced Senescence in Prelymphomagenic Thymocytes In Vivo Mol. Cell. Biol., March 1, 2008; 28(5): 1713 - 1723. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Guo, M. Dose, D. Kovalovsky, R. Chang, J. O'Neil, A. T. Look, H. von Boehmer, K. Khazaie, and F. Gounari {beta}-Catenin stabilization stalls the transition from double-positive to single-positive stage and predisposes thymocytes to malignant transformation Blood, June 15, 2007; 109(12): 5463 - 5472. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Winrow, D. G. Pankratz, C. R. T. Vibat, T.J. Bowen, M. A. Callahan, A. J. Warren, B. S. Hilbush, A. Wynshaw-Boris, K. W. Hasel, Z. Weaver, et al. Aberrant recombination involving the granzyme locus occurs in Atm-/- T-cell lymphomas Hum. Mol. Genet., September 15, 2005; 14(18): 2671 - 2684. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Sakata, J. Inoue, H. Ohi, H. Kosugi-Okano, Y. Mishima, K. Hatakeyama, O. Niwa, and R. Kominami Involvement of V(D)J recombinase in the generation of intragenic deletions in the Rit1/Bcl11b tumor suppressor gene in {gamma}-ray-induced thymic lymphomas and in normal thymus of the mouse Carcinogenesis, June 1, 2004; 25(6): 1069 - 1075. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Mendrysa, M. K. McElwee, J. Michalowski, K. A. O'Leary, K. M. Young, and M. E. Perry mdm2 Is Critical for Inhibition of p53 during Lymphopoiesis and the Response to Ionizing Irradiation Mol. Cell. Biol., January 15, 2003; 23(2): 462 - 472. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. S. Chervinsky, D. H. Lam, M. P. Melman, K. W. Gross, and P. D. Aplan scid Thymocytes with TCR{beta} Gene Rearrangements Are Targets for the Oncogenic Effect of SCL and LMO1 Transgenes Cancer Res., September 1, 2001; 61(17): 6382 - 6387. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Williams, I. Grandal, D. J. Vesprini, U. Wojtyra, J. S. Danska, and C. J. Guidos Irradiation Promotes V(D)J Joining and RAG-Dependent Neoplastic Transformation in SCID T-Cell Precursors Mol. Cell. Biol., January 15, 2001; 21(2): 400 - 413. [Abstract] [Full Text] |
||||
![]() |
R. Wen, D. Wang, C. McKay, K. D. Bunting, J.-C. Marine, E. F. Vanin, G. P. Zambetti, S. J. Korsmeyer, J. N. Ihle, and J. L. Cleveland Jak3 Selectively Regulates Bax and Bcl-2 Expression To Promote T-Cell Development Mol. Cell. Biol., January 15, 2001; 21(2): 678 - 689. [Abstract] [Full Text] |
||||
![]() |
J. E. French, G. D. Lacks, C. Trempus, J. K. Dunnick, J. Foley, J. Mahler, R. R. Tice, and R. W. Tennant Loss of heterozygosity frequency at the Trp53 locus in p53-deficient (+/-) mouse tumors is carcinogen-and tissue-dependent Carcinogenesis, January 1, 2001; 22(1): 99 - 106. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. L. Poetschke, D. B. Klug, S. N. Perkins, T. T.Y. Wang, E. R. Richie, and S. D. Hursting Effects of calorie restriction on thymocyte growth, death and maturation Carcinogenesis, November 1, 2000; 21(11): 1959 - 1964. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. K. Petiniot, Z. Weaver, C. Barlow, R. Shen, M. Eckhaus, S. M. Steinberg, T. Ried, A. Wynshaw-Boris, and R. J. Hodes Recombinase-activating gene (RAG) 2-mediated V(D)J recombination is not essential for tumorigenesis in Atm-deficient mice PNAS, June 6, 2000; 97(12): 6664 - 6669. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Gomez, K. Z. Clarkin, E. Kraig, A. J. Infante, and E. R. Richie TCR V{beta} repertoire restriction and lack of CDR3 conservation implicate TCR-superantigen interactions in promoting the clonal evolution of murine thymic lymphomas Int. Immunol., March 1, 2000; 12(3): 263 - 270. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. J. Vanasse, P. Concannon, and D. M. Willerford Regulated Genomic Instability and Neoplasia in the Lymphoid Lineage Blood, December 15, 1999; 94(12): 3997 - 4010. [Full Text] [PDF] |
||||
![]() |
M.-J. Liao and T. Van Dyke Critical role for Atm in suppressing V(D)J recombination-driven thymic lymphoma Genes & Dev., May 15, 1999; 13(10): 1246 - 1250. [Abstract] [Full Text] |
||||
![]() |
T. Kamijo, S. Bodner, E. van de Kamp, D. H. Randle, and C. J. Sherr Tumor Spectrum in ARF-deficient Mice Cancer Res., May 1, 1999; 59(9): 2217 - 2222. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. V. Iozzo, F. Chakrani, D. Perrotti, D. J. McQuillan, T. Skorski, B. Calabretta, and I. Eichstetter Cooperative action of germ-line mutations in decorin and p53 accelerates lymphoma tumorigenesis PNAS, March 16, 1999; 96(6): 3092 - 3097. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-J. Liao, X.-X. Zhang, R. Hill, J. Gao, M. B. Qumsiyeh, W. Nichols, and T. Van Dyke No Requirement for V(D)J Recombination in p53-Deficient Thymic Lymphoma Mol. Cell. Biol., June 1, 1998; 18(6): 3495 - 3501. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |